» Articles » PMID: 14592840

Adhesion to E-selectin Promotes Growth Inhibition and Apoptosis of Human and Murine Hematopoietic Progenitor Cells Independent of PSGL-1

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2003 Nov 1
PMID 14592840
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Although both P- and E-selectin are constitutively expressed on bone marrow endothelial cells, their role in the regulation of hematopoiesis has only recently been investigated. We have previously shown that P-selectin glycoprotein ligand-l (PSGL-1/CD162) is expressed by primitive human bone marrow CD34+ cells, mediates their adhesion to P-selectin, and, more importantly, inhibits their proliferation. We now demonstrate that adhesion to E-selectin inhibits the proliferation of human CD34+ cells isolated either from human umbilical cord blood, adult mobilized blood, or steady-state bone marrow. Furthermore, a subpopulation, which does not contain the most primitive hematopoietic progenitor cells, undergoes apoptosis following E-selectin-mediated adhesion. The same phenomenon was observed in cells isolated from mouse bone marrow. Using lineage-negative Sca-1+ c-KIT+ bone marrow cells from PSGL-1(-/-) and wild-type mice, we establish that PSGL-1 is not the ligand involved in E-selectin-mediated growth inhibition and apoptosis. Moreover, stable transfection of the human myeloid cell line K562 (which does not express PSGL-1) with alpha(1,3) fucosyltransferase VII alone was sufficient to recapitulate the E-selectin-mediated growth inhibition and apoptosis observed in hematopoietic progenitor cells. These data demonstrate that an E-selectin ligand(s) other than PSGL-1 transduces growth inhibitory and proapoptotic signals and requires posttranslational fucosylation to be functional.

Citing Articles

Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia.

Grenier J, Testut C, Fauriat C, Mancini S, Aurrand-Lions M Front Immunol. 2021; 12:756231.

PMID: 34867994 PMC: 8636127. DOI: 10.3389/fimmu.2021.756231.


Rare Modifier Variants Alter the Severity of Cardiovascular Disease in Pseudoxanthoma Elasticum: Identification of Novel Candidate Modifier Genes and Disease Pathways Through Mixture of Effects Analysis.

De Vilder E, Martin L, Leftheriotis G, Coucke P, Van Nieuwerburgh F, Vanakker O Front Cell Dev Biol. 2021; 9:612581.

PMID: 34169069 PMC: 8218811. DOI: 10.3389/fcell.2021.612581.


Acute Myeloid Leukemia Chemo-Resistance Is Mediated by E-selectin Receptor CD162 in Bone Marrow Niches.

Erbani J, Tay J, Barbier V, Levesque J, Winkler I Front Cell Dev Biol. 2020; 8:668.

PMID: 32793603 PMC: 7393995. DOI: 10.3389/fcell.2020.00668.


Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance.

Barbier V, Erbani J, Fiveash C, Davies J, Tay J, Tallack M Nat Commun. 2020; 11(1):2042.

PMID: 32341362 PMC: 7184728. DOI: 10.1038/s41467-020-15817-5.


Leveraging fluorinated glucosamine action to boost antitumor immunity.

Dimitroff C Curr Opin Immunol. 2012; 25(2):206-13.

PMID: 23219268 PMC: 3604137. DOI: 10.1016/j.coi.2012.11.003.